nav-left cat-right
cat-right

7th Annual Protein Kinases Congress 10-12 March 20...

Innovating kinase inhibitor development is the key to successful clinical development. At Informa Life Sciences 7th Annual Protein Kinases Congress hear the latest thinking and strategies towards creating a selective inhibitor. Learn about new targets, industry trends in structure-based drug design, clinical case-studies and discuss the issue of cardiotoxicity. For more information visit:...

PepCon-2008 Shenzhen, China on April 22-24, 2008

Advances in peptide and protein researches are occurring at an ever increasing pace, in a wide range of fields and scientific disciplines. At this exciting time, it is especially important to promote scientific and technological exchange and cooperation at the international level. To establish of a new educational and networking platform for protein and peptide sciences for international academic and industrial institutions...

Strategic Diagnostics Launches Initial Oncology-Ta...

NEWARK, Del., Oct. 2 /PRNewswire-FirstCall/ — Strategic Diagnostics Inc. — today announced the launch of a new internet based catalog of antibody reagents in support of oncology-based research and discovery. These high-quality reagents have all been manufactured utilizing SDI’s proprietary Genomic Antibody Technology(TM) and will carry the SEQer(TM) brand. The catalog is available at...

Proteomic profiling to assess genetically modified...

Wednesday, January 11, 2006 By Sirpa O. Kärenlampi and Satu J. Lehesranta It is generally accepted that traditional food is safe for the majority of consumers. For the introduction of a new variant or cultivar developed from a traditional crop plant, maximum limits have been set in some cases, e.g., for potato and oilseed rape, to the content of known toxins. The requirements are much more stringent if the crop is...
Page 5 of 512345